Injectable hydrogel with MSN/microRNA-21-5p complexes reduces infarct size in vivo March 11, 2021 No Comments
SBI and University of Oxford initiate phase II study of cardioprotective agent using 5-ALA March 9, 2021 No Comments
MicroRNA switch therapy self-assembles into nanoparticles to treat atherosclerosis Feb. 26, 2021 No Comments
Longeveron completes phase I study of Lomecel-B in hypoplastic left heart syndrome Feb. 25, 2021 No Comments
5-HT2B as a novel therapeutic target to improve microstructural remodeling post-MI Jan. 26, 2021 No Comments